SCHEMBL5587775

SCHEMBL5587775

Cc1ccccc1-c1cccc(O)c1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 0.62
ALDH1A1 P00352 6/20 0.50
ATM Q13315 3/20 0.50
MGAM O43451 2/20 0.49
GAA P10253 2/20 0.49
SI P14410 2/20 0.49
MGAM2 Q2M2H8 2/20 0.49
HPGD P15428 6/20 0.48
ALOX15 P16050 4/20 0.48
HSD17B10 Q99714 4/20 0.48
RECQL P46063 3/20 0.48
LMNA P02545 3/20 0.48
EGFR P00533 2/20 0.48
CA2 P00918 2/20 0.48
FYN P06241 2/20 0.48
MMP9 P14780 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ADAMTS4 O75173 1/20 0.48
CA1 P00915 1/20 0.48
MMP2 P08253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30238150 1.00 TRPA1 (0.62) TRPA1ALDH1A1ATMMGAMGAA
SCHEMBL16768986 0.89 TRPA1 (0.67) TRPA1ALDH1A1ATMMGAMGAA
SCHEMBL1005238 0.88 ALDH1A1 (0.57) TRPA1ALDH1A1ATMHPGDHSD17B10
SCHEMBL673891 0.86 ALDH1A1 (0.62) TRPA1ALDH1A1ATMHPGDHSD17B10
SCHEMBL2870993 0.84 TRPA1 (0.48) TRPA1ALDH1A1ATMHPGDALOX15
SCHEMBL5589909 0.84 TRPA1 (0.60) TRPA1ALDH1A1ATMMGAMGAA
SCHEMBL31337248 0.83 HPGD (0.52) TRPA1ALDH1A1ATMMGAMGAA
SCHEMBL758202 0.83 HPGD (0.52) TRPA1ALDH1A1ATMMGAMGAA
SCHEMBL9973588 0.83 HPGD (0.61) TRPA1ALDH1A1GAAHPGDALOX15
SCHEMBL337585 0.83 ALDH1A1 (0.69) TRPA1ALDH1A1MGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102002139-B Method for preparing modified phenolic resin for coating with cresol residue LANZHOU PETROCHEMICAL COLLEGE OF VOCATIONAL TECHNOLOGY 2012-06-20 CN disclosed
CN-101967333-B Method for preparing phenolic resin from phenols residues and application thereof to production of coating LANZHOU PETROCHEMICAL VOC TECH COLLEGE 2012-02-22 CN disclosed
CN-102002139-A Method for preparing modified phenolic resin for coating with cresol residue LANZHOU PETROCHEMICAL COLLEGE OF VOCATIONAL TECHNOLOGY 2011-04-06 CN disclosed
CN-101967333-A Method for preparing phenolic resin from phenols residues and application thereof to production of coating LANZHOU PETROCHEMICAL VOC TECH COLLEGE 2011-02-09 CN disclosed
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 TRPA1 1912/4885ALDH1A1 2181/4885ATM 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.